Causal associations of brain structure with bone mineral density: a large-scale genetic correlation study

Abstract

In this study, we aimed to investigate the causal associations of brain structure with bone mineral density (BMD). Based on the genome-wide association study (GWAS) summary statistics of 1 325 brain imaging-derived phenotypes (BIDPs) of brain structure from the UK Biobank and GWAS summary datasets of 5 BMD locations, including the total body, femoral neck, lumbar spine, forearm, and heel from the GEFOS Consortium, linkage disequilibrium score regression (LDSC) was conducted to determine the genetic correlations, and Mendelian randomization (MR) was then performed to explore the causal relationship between the BIDPs and BMD. Several sensitivity analyses were performed to verify the strength and stability of the present MR outcomes. To increase confidence in our findings, we also performed confirmatory MR between BIDPs and osteoporosis. LDSC revealed that 1.93% of BIDPs, with a false discovery rate (FDR) < 0.01, were genetically correlated with BMD. Additionally, we observed that 1.31% of BIDPs exhibited a significant causal relationship with BMD (FDR < 0.01) through MR. Both the LDSC and MR results demonstrated that the BIDPs “Volume of normalized brain,” “Volume of gray matter in Left Inferior Frontal Gyrus, pars opercularis,” “Volume of Estimated Total Intra Cranial” and “Volume-ratio of brain segmentation/estimated total intracranial” had strong associations with BMD. Interestingly, our results showed that more left BIDPs were causally associated with BMD, especially within and around the left frontal region. In conclusion, a part of the brain structure causally influences BMD, which may provide important perspectives for the prevention of osteoporosis and offer valuable insights for further research on the brain-bone axis.

References

[1] Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am. J. Obstet. Gynecol., 2006, 194: S3-S11

[2] Kelsey JL. Risk factors for osteoporosis and associated fractures. Public Health Rep., 1989, 104: 14-20

[3] Black DM, Rosen CJ. Clinical practice. Postmenopausal osteoporosis. N. Engl. J. Med., 2016, 374: 254-262

[4] Maryanovich M, Takeishi S, Frenette PS. Neural regulation of bone and bone marrow. Cold Spring Harb. Perspect Med, 2018, 8: a031344

[5] Adams HH et al. Novel genetic loci underlying human intracranial volume identified through genome-wide association. Nat. Neurosci., 2016, 19: 1569-1582

[6] Takano Y et al. Hypoperfusion in the posterior cingulate cortex is associated with lower bone mass density in elderly women with osteopenia and Alzheimer’s disease. Clin. Exp. Pharmacol. Physiol., 2020, 47: 365-371

[7] Qin W, Bauman WA, Cardozo CP. Evolving concepts in neurogenic osteoporosis. Curr. Osteoporos. Rep., 2010, 8: 212-218

[8] Roos PM. Osteoporosis in neurodegeneration. J. Trace Elem. Med. Biol., 2014, 28: 418-421

[9] Raglione LM, Sorbi S, Nacmias B. Osteoporosis and Parkinson’s disease. Clin. Cases Min. Bone Metab., 2011, 8: 16-18

[10] Antoniou G, Benetos IS, Vlamis J, Pneumaticos SG. Bone mineral density post a spinal cord injury: a review of the current literature guidelines. Cureus, 2022, 14: e23434

[11] Caplliure-Llopis J et al. Poor bone quality in patients with amyotrophic lateral sclerosis. Front. Neurol., 2020, 11: 599216

[12] Kumar S et al. Alzheimer’s disease and its association with bone health: a case-control study. Cureus, 2021, 13: e13772

[13] Mohammad AF, Khan KA, Galvin L, Hardiman O, O’Connell PG. High incidence of osteoporosis and fractures in an aging post-polio population. Eur. Neurol., 2009, 62: 369-374

[14] Simonsen CS et al. Bone mineral density in patients with multiple sclerosis, hereditary ataxia or hereditary spastic paraplegia after at least 10 years of disease - a case control study. BMC Neurol., 2016, 16

[15] Douaud G et al. Brain microstructure reveals early abnormalities more than two years prior to clinical progression from mild cognitive impairment to Alzheimer’s disease. J. Neurosci. Off. J. Soc. Neurosci., 2013, 33: 2147-2155

[16] Miller KL et al. Multimodal population brain imaging in the UK Biobank prospective epidemiological study. Nat. Neurosci., 2016, 19: 1523-1536

[17] Alfaro-Almagro F et al. Image processing and Quality Control for the first 10,000 brain imaging datasets from UK Biobank. NeuroImage, 2018, 166: 400-424

[18] Ma B et al. Causal associations of anthropometric measurements with fracture risk and bone mineral density: a mendelian randomization study. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res., 2021, 36: 1281-1287

[19] Bulik-Sullivan BK et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet., 2015, 47: 291-295

[20] Nitsch D et al. Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials. Am. J. Epidemiol., 2006, 163: 397-403

[21] Raichle ME, Mintun MA. Brain work and brain imaging. Annu. Rev. Neurosci., 2006, 29: 449-476

[22] Blake GM, Fogelman I. The clinical role of dual energy X-ray absorptiometry. Eur. J. Radio., 2009, 71: 406-414

[23] Huang S et al. Neural regulation of bone remodeling: Identifying novel neural molecules and pathways between brain and bone. J. Cell. Physiol., 2019, 234: 5466-5477

[24] Takeda S et al. Leptin regulates bone formation via the sympathetic nervous system. Cell, 2002, 111: 305-317

[25] Baldock PA et al. Hypothalamic Y2 receptors regulate bone formation. J. Clin. Investig., 2002, 109: 915-921

[26] Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature, 2003, 423: 349-355

[27] Takeda S. Osteoporosis: a neuroskeletal disease. Int. J. Biochem. cell Biol., 2009, 41: 455-459

[28] Grodzinsky, Y. & Amunts, K. Broca’s region. (Oxford University Press, 2006).

[29] Abdul-Kareem IA, Stancak A, Parkes LM, Sluming V. Increased gray matter volume of left pars opercularis in male orchestral musicians correlate positively with years of musical performance. J. Magn. Reson. Imaging.: JMRI, 2011, 33: 24-32

[30] Iacoboni M et al. Cortical mechanisms of human imitation. Science, 1999, 286: 2526-2528

[31] Rizzolatti G et al. Localization of grasp representations in humans by PET: 1. Observation versus execution. Exp. Brain Res., 1996, 111: 246-252

[32] Binkofski F et al. A parieto-premotor network for object manipulation: evidence from neuroimaging. Exp. Brain Res., 1999, 128: 210-213

[33] Krams M, Rushworth MF, Deiber MP, Frackowiak RS, Passingham RE. The preparation, execution and suppression of copied movements in the human brain. Exp. Brain Res., 1998, 120: 386-398

[34] Koski L et al. Modulation of motor and premotor activity during imitation of target-directed actions. Cereb. Cortex, 2002, 12: 847-855

[35] Koechlin E, Jubault T. Broca’s area and the hierarchical organization of human behavior. Neuron, 2006, 50: 963-974

[36] Stefanidou M et al. Bone mineral density measurements and association with brain structure and cognitive function: the framingham offspring cohort. Alzheimer Dis. Assoc. Disord., 2021, 35: 291-297

[37] Woodward ND, Heckers S. Brain structure in neuropsychologically defined subgroups of schizophrenia and psychotic bipolar disorder. Schizophr. Bull., 2015, 41: 1349-1359

[38] Misra M, Papakostas GI, Klibanski A. Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism. J. Clin. Psychiatry, 2004, 65: 1607-1618

[39] Williams LJ et al. The association between depressive and anxiety symptoms and bone mineral density in the general population: the HUNT Study. J. Affect. Disord., 2011, 131: 164-171

[40] Zhou R, Deng J, Zhang M, Zhou HD, Wang YJ. Association between bone mineral density and the risk of Alzheimer’s disease. J. Alzheimer’s Dis. JAD, 2011, 24: 101-108

[41] Jung DU et al. Bone mineral density and osteoporosis risk in older patients with schizophrenia. J. Clin. Psychopharmacol., 2011, 31: 406-410

[42] Shan X et al. Disrupted regional homogeneity in drug-naive patients with bipolar disorder. Front. Psychiatry, 2020, 11: 825

[43] Chandrasekaran V et al. Association between bipolar spectrum disorder and bone health: a meta-analysis and systematic review protocol. BMJ Open, 2017, 7: e013981

[44] Hsu CC et al. Increased risk of fracture in patients with bipolar disorder: a nationwide cohort study. Soc. Psychiatry Psychiatr. Epidemiol., 2016, 51: 1331-1338

[45] Courchesne E et al. Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers. Radiology, 2000, 216: 672-682

[46] Kamdar MR, Gomez RA, Ascherman JA. Intracranial volumes in a large series of healthy children. Plast. Reconstr. Surg., 2009, 124: 2072-2075

[47] Davis PJM, Wright EA. A new method for measuring cranial cavity volume and its application to the assessment of cerebral atrophy at autopsy. Neuropathol. Appl. Neurobiol, 1977, 3: 341-358

[48] Bae IS, Kim JM, Cheong JH, Han MH, Ryu JI. Association between cerebral atrophy and osteoporotic vertebral compression fractures. PLoS One, 2019, 14: e0224439

[49] Loskutova N, Honea RA, Vidoni ED, Brooks WM, Burns JM. Bone density and brain atrophy in early Alzheimer’s disease. J. Alzheimer’s Dis. JAD, 2009, 18: 777-785

[50] Bae IS, Kim JM, Cheong JH, Ryu JI, Han MH. Association between bone mineral density and brain parenchymal atrophy and ventricular enlargement in healthy individuals. Aging, 2019, 11: 8217-8238

[51] Saboori P, Sadegh A. Histology and morphology of the brain subarachnoid trabeculae. Anat. Res. Int., 2015, 2015: 279814

[52] Grant SF et al. Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nat. Genet., 1996, 14: 203-205

[53] Richard E et al. Morphometric changes in the cortical microvascular network in Alzheimer’s disease. J. Alzheimer’s Dis. JAD, 2010, 22: 811-818

[54] Miller VM et al. The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned? Menopause, 2019, 26: 1071-1084

[55] Wong IP, Zengin A, Herzog H, Baldock PA. Central regulation of bone mass. Semin. Cell Dev. Biol., 2008, 19: 452-458

[56] Hökfelt T et al. Neuropeptide Y: some viewpoints on a multifaceted peptide in the normal and diseased nervous system. Brain Res. Brain Res. Rev., 1998, 26: 154-166

[57] Lindefors N, Brené S, Herrera-Marschitz M, Persson H. Regulation of neuropeptide Y gene expression in rat brain. Ann. N. Y. Acad. Sci., 1990, 611: 175-185

[58] Rogers, L. J. & Andrew, R. Comparative vertebrate lateralization. (Cambridge University Press, 2002).

[59] Ocklenburg S, Güntürkün O. Hemispheric asymmetries: the comparative view. Front. Psychol., 2012, 3: 5

[60] Concha ML, Signore IA, Colombo A. Mechanisms of directional asymmetry in the zebrafish epithalamus. Semin. Cell Dev. Biol., 2009, 20: 498-509

[61] Hervé P-Y, Zago L, Petit L, Mazoyer B, Tzourio-Mazoyer NJ. Revisiting human hemispheric specialization with neuroimaging. Trends Cogn. Sci., 2013, 17: 69-80 T. i. c. s

[62] Gotts SJ et al. Two distinct forms of functional lateralization in the human brain. Proc. Natl. Acad. Sci. USA, 2013, 110: E3435-E3444

[63] Guadalupe T et al. Asymmetry within and around the human planum temporale is sexually dimorphic and influenced by genes involved in steroid hormone receptor activity. Cortex, 2015, 62: 41-55

[64] Guadalupe T et al. Measurement and genetics of human subcortical and hippocampal asymmetries in large datasets. Hum. Brain Mapp., 2014, 35: 3277-3289

[65] Zhu D et al. Total brain volumetric measures and schizophrenia risk: a two-sample mendelian randomization study. Front. Genet., 2022, 13: 782476

[66] van der Sluis S, Posthuma D, Nivard MG, Verhage M, Dolan CV. Power in GWAS: lifting the curse of the clinical cut-off. Mol. Psychiatry, 2013, 18: 2-3

[67] Elliott LT et al. Genome-wide association studies of brain imaging phenotypes in UK Biobank. Nature, 2018, 562: 210-216

[68] Bulik-Sullivan BK et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet., 2015, 47: 291-295

[69] Xu J et al. Assessing the Association between Important Dietary Habits and Osteoporosis: a genetic correlation and two-sample mendelian randomization study. Nutrients, 2022, 14: 2656

[70] Bulik-Sullivan BK et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet., 2015, 47: 291-295

[71] Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ, 2018, 362: k601

[72] Kamat MA et al. PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinforma. (Oxf., Engl.), 2019, 35: 4851-4853

[73] Pagoni P, Dimou NL, Murphy N, Stergiakouli E. Using Mendelian randomisation to assess causality in observational studies. Evid. Based Ment. Health, 2019, 22: 67-71

[74] Wang C et al. Causal associations of obesity related anthropometric indicators and body compositions with knee and hip arthritis: a large-scale genetic correlation study. Front. Endocrinol., 2022, 13: 1011896

[75] Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol., 2015, 44: 512-525

[76] Hemani G, Tilling K, Davey Smith G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet., 2017, 13: e1007081

[77] Armstrong RA. When to use the Bonferroni correction. Ophthalmic Physiol. Opt., 2014, 34: 502-508

[78] Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc.: Ser. B Methodol, 1995, 57: 289-300

Funding

National Natural Science Foundation of China (National Science Foundation of China)(82172399)

Natural Science Foundation of Hunan Province (Hunan Provincial Natural Science Foundation) 2020JJ4897